Theravia SAS
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
16 Rue Montrosier, Neuilly-sur-Seine, Il...Phone Number
+33 172690186Website
www.theravia.comRevenue
$17.6 MillionIndustry
About Theravia SAS
Is Theravia SAS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Theravia SAS
Check out if Theravia SAS is spiking on competitors!
Funding: Get notified immidiatlly once Theravia SAS has new funding data
Check if Theravia SAS has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Theravia SAS launches new products
Click to see if Theravia SAS had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Theravia SAS recently announced quarterly report
Theravia SAS, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Theravia SAS as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Theravia SAS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Theravia SAS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Theravia SAS.
Theravia SAS Tech Stack
A closer look at the technologies used by Theravia SAS
Theravia SAS News & Media
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Theravia SAS
Theravia is an international pharmaceutical laboratory that specializes in rare or neglected diseases, formed through the merger of Addmedica and CTRS. The company is dedicated to addressing the unmet medical needs of patients suffering from these challenging conditions by developing innovative therapies. With a portfolio of six registered products... Read More